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Objective  
For a successful pregnancy to occur, 
foreign genetic material such as the 
allogeneic fetus must be tolerated within 
the maternal host.  Indoleamine 2,3-
dioxygenase (IDO) is an enzyme 
induced by pro-inflammatory cytokines 
that has been shown to be key to this 
process.  Obesity as a pro-inflammatory 
state is associated with poor obstetric 
outcomes.  The primary objective of this 
study is to investigate the relationship 
between obesity and IDO activity.   
Methods 
In this case-control study, 199 obese 
and 194 non-obese participants had 
plasma samples analyzed for IDO 
activity throughout gestation and at 
delivery.  IDO activity was measured 
using a published colorimetric method.  
Clinical data and biosamples were 
obtained from the University of Iowa 
Maternal Fetal Tissue Bank (IRB # 
200910784).  Bivariate and multivariable 
analyses were performed.  α = 0.05 
Results 
IDO activity is significantly associated 
with obesity and gestational age, 
particularly in the second trimester.  
Logistic regression revealed significantly 
lower levels of IDO activity in the setting 
of fetal growth restriction in the second 
trimester. 
Conclusions 
This study suggests an association 
between IDO activity and obesity and 
gestational age.  The lower IDO activity 
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level seen in higher WHO Obesity 
classes is consistent with the pro-
inflammatory nature of obesity in 
pregnancy.  Furthermore, the 
association of a lower IDO activity with 
IUGR supports a possible immunologic 
etiology of a strong inflammatory 
response leading to placental 
dysfunction.  This not only points to a 
future direction for research in this area 
but may hold potential for being a 
therapeutic avenue to alter the course of 
this poor pregnancy outcome before it 
begins. 
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